| Objective evaluation of anosmia and ageusia in COVID‐19 patients: Single‐center experience on 72 cases LA Vaira, G Deiana, AG Fois, P Pirina, G Madeddu, A De Vito, S Babudieri, ... Head & neck 42 (6), 1252-1258, 2020 | 582 | 2020 |
| Olfactory and gustatory function impairment in COVID‐19 patients: Italian objective multicenter‐study LA Vaira, C Hopkins, G Salzano, M Petrocelli, A Melis, M Cucurullo, ... Head & neck 42 (7), 1560-1569, 2020 | 300 | 2020 |
| Coronavirus disease 2019 (COVID‐19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) Omicron variant P Boscolo‐Rizzo, G Tirelli, P Meloni, C Hopkins, G Madeddu, A De Vito, ... International forum of allergy & rhinology, 2022 | 98 | 2022 |
| Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy A De Vito, N Geremia, V Fiore, E Princic, S Babudieri, G Madeddu Eur Rev Med Pharmacol Sci 24 (14), 7861-7868, 2020 | 80 | 2020 |
| Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes A De Vito, V Fiore, E Princic, N Geremia, CM Panu Napodano, ... Plos one 16 (3), e0248009, 2021 | 73 | 2021 |
| The De Ritis ratio as prognostic biomarker of in‐hospital mortality in COVID‐19 patients A Zinellu, F Arru, A De Vito, A Sassu, G Valdes, V Scano, E Zinellu, ... European journal of clinical investigation 51 (1), e13427, 2021 | 69 | 2021 |
| Severity of lung involvement on chest X-rays in SARS-coronavirus-2 infected patients as a possible tool to predict clinical progression: an observational retrospective analysis … E Baratella, P Crivelli, C Marrocchio, AM Bozzato, AD Vito, G Madeddu, ... Jornal Brasileiro de Pneumologia 46 (5), 2020 | 53 | 2020 |
| New onset of smell and taste loss are common findings also in patients with symptomatic COVID‐19 after complete vaccination LA Vaira, A De Vito, JR Lechien, CM Chiesa‐Estomba, M Mayo‐Yàñez, ... The Laryngoscope, 2021 | 43 | 2021 |
| A case of vasculitis-like skin eruption associated with COVID-19 N Geremia, A De Vito, S Gunnella, V Fiore, E Princic, CP Napodano, ... Infectious Diseases in Clinical Practice 28 (6), e30-e31, 2020 | 39 | 2020 |
| Safety and efficacy of molnupiravir in SARS‐CoV‐2 infected patients: a real‐life experience A De Vito, A Colpani, A Bitti, B Zauli, MC Meloni, M Fois, L Denti, S Bacciu, ... Journal of Medical Virology, 2022 | 36 | 2022 |
| The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients A Zinellu, A De Vito, V Scano, P Paliogiannis, V Fiore, G Madeddu, ... The Journal of Infection in Developing Countries 15 (03), 353-359, 2021 | 36 | 2021 |
| Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19 RN Dallocchio, A Dessì, A De Vito, G Delogu, PA Serra, G Madeddu Eur Rev Med Pharmacol Sci 25 (5), 2435-2448, 2021 | 33 | 2021 |
| Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naive patients: Results from a multicenter cohort study B Rossetti, G Baldin, G Sterrantino, S Rusconi, A De Vito, A Giacometti, ... Antiviral research 169, 104552, 2019 | 33 | 2019 |
| Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience A De Vito, N Geremia, E Princic, C Fanelli, CM Panu Napodano, ... Eur Rev Med Pharmacol Sci 25 (1), 523-526, 2021 | 27 | 2021 |
| Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study LA Vaira, A De Vito, G Deiana, C Pes, F Giovanditto, V Fiore, JR Lechien, ... European Archives of Oto-Rhino-Laryngology, 1-6, 2021 | 26 | 2021 |
| Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? LA Vaira, A De Vito, G Deiana, C Pes, F Giovanditto, V Fiore, JR Lechien, ... The Journal of Laryngology & Otology 135 (8), 723-728, 2021 | 25 | 2021 |
| Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE … M Fabbiani, B Rossetti, A Ciccullo, L Oreni, F Lagi, L Celani, M Colafigli, ... HIV medicine 22 (9), 843-853, 2021 | 24 | 2021 |
| Correlations Between Olfactory Psychophysical Scores and SARS‐CoV‐2 Viral Load in COVID‐19 Patients LA Vaira, G Deiana, JR Lechien, A De Vito, A Cossu, M Dettori, A Del Rio, ... The Laryngoscope 131 (10), 2312-2318, 2021 | 24 | 2021 |
| Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression A De Vito, A Colpani, L Saderi, M Puci, B Zauli, V Fiore, M Fois, ... Viruses 15 (1), 71, 2023 | 23 | 2023 |
| Five years with dolutegravir plus lamivudine as a switch strategy: much more than a positive finding A Ciccullo, V Borghi, A Giacomelli, MV Cossu, G Sterrantino, A Latini, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 88 (3), 234-237, 2021 | 23 | 2021 |
Giordano MadedduUniversity of SassariVerified email at uniss.it
